ASTH
Astrana Health
$38.19
−$2.12 (−5.26%)Jul 27, 2026
Key metrics
The numbers that frame ASTH today
- Market cap
- $2.13B
- P/E (TTM)
- 70.4
- EV / FCF
- 17.5
- Gross margin
- 10.7%
- EV / Sales
- 0.8
- ROIC
- 11.2%
- Div yield
- 0%
- Debt / equity
- 1.3
- 52wk Low
- $18.08
- 52wk High
- $51.60
Growth
Revenue and earnings trend for ASTH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ASTH
Is Astrana Health a good buy?
Yes. Astrana Health has excellent momentum, and it outweighs the weak quality here. Growth looks mixed. The support signal is useful, but not decisive. We think Astrana Health is selling at a low price.
What is the market capitalization of ASTH?
Astrana Health's market capitalization is $2.13B.
What is the P/E ratio for ASTH stock?
Astrana Health's current P/E ratio is 70.4.
What is the 52-week high for ASTH stock?
The 52-week high for Astrana Health is $51.60. The current close of $38.19 is 26% below that high.
What is the 52-week low for ASTH stock?
The 52-week low for Astrana Health is $18.08. The current close of $38.19 is 111.2% above that low.
Does ASTH stock pay dividends?
Astrana Health does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ASTH?
Astrana Health's Debt / Equity ratio is 1.33.